Ligand profile
ZINC2869073
Virtual-screening candidate from ZINC.
Bound to: KP13_03795 — dTDP-4-dehydrorhamnose 3,5-epimerase in cps region
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC2869073- UniProt (similar protein)
P9WH10- Tanimoto
- 0.673
- Target protein
- KP13_03795
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 43.6
- −1 ≤ LogP ≤ 5 3.89
- MW ≤ 500 Da 286.4
- LogP ≤ 5 3.89
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 43.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCCCSc1nnc2c3ccccc3n(CC)c2n1CCCCSc1nnc2c3ccccc3n(CC)c2n1
InChI=1S/C15H18N4S/c1-3-5-10-20-15-16-14-13(17-18-15)11-8-6-7-9-12(11)19(14)4-2/h6-9H,3-5,10H2,1-2H3InChI=1S/C15H18N4S/c1-3-5-10-20-15-16-14-13(17-18-15)11-8-6-7-9-12(11)19(14)4-2/h6-9H,3-5,10H2,1-2H3
AJUCXMKABBPHGD-UHFFFAOYSA-NAJUCXMKABBPHGD-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- CHEMBL589101
- Homolog
- P9WH10
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC2869073 →
- ZINC ZINC20 ZINC2869073 →
- UniProt UniProt P9WH10 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC2869073”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03795.
PDB 5
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 5
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).